Study skin and blood signs in ichthyosis
Part of Genetic & congenital, Skin clinical trials.
This study looks at “skin and blood biomarkers,” meaning measurable signs in the body, in people with ichthyosis to better understand the condition. It may help researchers find ways to track disease activity and evaluate future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 1 and 60 years old when you enroll
- If you have ichthyosis, your diagnosis must be Netherton syndrome, lamellar ichthyosis, or another ichthyosis type
- For ichthyosis: avoid anti-inflammatory pills by 1 month before blood/skin sampling
- For ichthyosis: avoid anti-inflammatory creams by 1 week before sampling
- For skin sampling: do not apply lotions (emollients) to the exact biopsy spots within 12 hours before the biopsy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new moisturizer called Doublebase Once, applied once daily, to see if it is safe and works well for people with ichthyosis. Participants will use the study moisturizer for one month instead of their usual one.
This study looks at the bacteria on the skin and in the gut of people with Netherton syndrome, a condition that affects the skin barrier and often causes allergies. It also compares these findings to healthy volunteers to understand how the microbiome might be different.
This trial tests if gentamicin injections can improve symptoms of hereditary ichthyosis, a genetic skin condition. It is for adults with moderate to severe forms caused by specific gene mutations.
This trial tests an oral drug called erlotinib (an EGFR inhibitor) in adults with certain genetic skin disorders. It aims to reduce symptoms of thickened, blistering or scaly skin. You may be able to join if you have a confirmed genetic form of these conditions and your skin is moderately affected.
This study looks at the immune system (lymphocytes) in people with a specific genetic form of ichthyosis called NIPAL4-related ARCI. It aims to understand the condition better, which may lead to improved treatments.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
Hear when a new Ichthyosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.